当前位置: X-MOL 学术RSC Adv. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
A review on the phytochemistry and pharmacology of the herb Scoparia dulcis L. for the potential treatment of metabolic syndrome
RSC Advances ( IF 3.9 ) Pub Date : 2021-09-22 , DOI: 10.1039/d1ra05090g
Zikang Jiang 1 , Jinghui Sung 1 , Xuyun Wang 2 , Yangyang Zhang 3 , Yaomiao Wang 1 , Haifeng Zhou 1 , Lei Wen 1
Affiliation  

This review discusses the chemical constituents and pharmacological effects of Scoparia dulcis L. (S. dulcis) plants. So far, approximately 160 compounds have been identified from S. dulcis, among which 115 compounds may be related to the treatment of metabolic syndrome. Extracts of S. dulcis have effects of reducing fasting blood glucose level, increasing the plasma insulin level, and stimulating insulin secretion to treat diabetes. They also produce antihyperlipidemic effects by increasing serum high-density lipoprotein levels, the anti-atherogenic index of plasma, and HMG-CoA reductase activity. The chemical composition of glutinol and glutinone, isolated from S. dulcis, provide potential anti-inflammatory effects. These compounds can also reduce total cholesterol, triacylglycerol, and low-density lipoprotein (LDL)-cholesterol and increase high-density lipoprotein (HDL)-cholesterol to provide the anti-atherosclerotic effect. S. dulcis exerts anti-arthritic properties through its effect on cytokine levels, significantly reducing IFN-γ and IL-6 levels and elevating IL-10 levels. The extracts carry out hepatoprotective effect by preventing the descent of the antioxidative enzymes of superoxide dismutase (SOD), glutathione peroxidase (GPx), glutathione reductase (GRd), and glutathione-S-transferase (GST). Therefore, S. dulcis provides new potential for medicine given its numerous therapeutic properties and can be promoted as a complementary or alternative therapy for patients with chronic conditions.

中文翻译:


草本植物 Scoparia dulcis L. 的植物化学和药理学综述,用于潜在治疗代谢综合征



本综述讨论了Scoparia dulcis L. ( S. dulcis ) 植物的化学成分和药理作用。迄今为止,已从S. dulcis中鉴定出约160种化合物,其中115种化合物可能与代谢综合征的治疗有关。甘草提取物具有降低空腹血糖水平、提高血浆胰岛素水平、刺激胰岛素分泌治疗糖尿病的作用。它们还通过增加血清高密度脂蛋白水平、血浆抗动脉粥样硬化指数和 HMG-CoA 还原酶活性来产生降血脂作用。从S. dulcis中分离出的谷黄醇和谷黄酮的化学成分具有潜在的抗炎作用。这些化合物还可以降低总胆固醇、三酰甘油和低密度脂蛋白(LDL)胆固醇,并增加高密度脂蛋白(HDL)胆固醇,以提供抗动脉粥样硬化作用。 S. dulcis通过影响细胞因子水平发挥抗关节炎特性,显着降低 IFN-γ 和 IL-6 水平并提高 IL-10 水平。提取物通过阻止超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GPx)、谷胱甘肽还原酶(GRd)和谷胱甘肽-S-转移酶(GST)等抗氧化酶的下降来发挥保肝作用。因此,鉴于其众多的治疗特性, S. dulcis为医学提供了新的潜力,并且可以作为慢性病患者的补充或替代疗法进行推广。
更新日期:2021-09-22
down
wechat
bug